Comparative Efficacy of Self-Help Multicomponent Lifestyle Medicine Intervention and Cognitive Behavioral Therapy for Depressive Symptoms
1 other identifier
interventional
90
1 country
1
Brief Summary
The objective of this proposed pilot randomized controlled trial is to examine the efficacy of self-help multicomponent lifestyle medicine intervention and cognitive behavioral therapy relative to a wait-list control group for alleviating depressive symptoms among Hong Kong Chinese adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Jan 2023
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2023
CompletedStudy Start
First participant enrolled
January 15, 2023
CompletedFirst Posted
Study publicly available on registry
January 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJanuary 20, 2023
January 1, 2023
8 months
January 11, 2023
January 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in The Patient Health Questionnaire (PHQ-9)
The PHQ-9, a 9-item questionnaire used for screening, diagnosing, monitoring, and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).
Baseline, immediate post-intervention, and 3-month post-intervention
Secondary Outcomes (9)
Change in The Generalized Anxiety Disorder 7-Item Scale (GAD-7)
Baseline, immediate post-intervention, and 3-month post-intervention
Change in the Insomnia Severity Index (ISI)
Baseline, immediate post-intervention, and 3-month post-intervention
Change in the Short Form (Six-Dimension) Health Survey (SF-6D)
Baseline, immediate post-intervention, and 3-month post-intervention
Change in The Short Multidimensional Inventory Lifestyle Evaluation (SMILE)
Baseline, immediate post-intervention, and 3-month post-intervention
Change in the Sheehan Disability Scale (SDS)
Baseline, immediate post-intervention, and 3-month post-intervention
- +4 more secondary outcomes
Study Arms (3)
Lifestyle medicine
EXPERIMENTALThe booklet-delivered multicomponent lifestyle medicine intervention includes six weekly sessions (i.e., participants are anticipated to access the intervention every day for 42 days) that are related to the following topics: (a) lifestyle psychoeducation, (b) exercise, (c) nutritional recommendations, (d) stress management, (e) sleep management, and (f) motivation and goal-setting techniques.
Cognitive behavioural therapy
ACTIVE COMPARATORThe booklet-delivered self-help CBT includes six weekly sessions (i.e., participants are anticipated to access the intervention every day for 42 days) that are related to psychoeducation of depression, cognitive behavioural techniques( e.g. behavioral activation, cognitive restructuring), stress management, mindfulness, goal-setting, and/or positive psychology.
Waitlist control
NO INTERVENTIONParticipants in the waitlist control group will be asked to maintain their typical activities during the trial period, and they will be given the lifestyle medicine booklet or CBT booklet based on their preference following the completion of the 3-month follow-up assessment (Week 19).
Interventions
6 weeks booklet-delivered multicomponent lifestyle medicine intervention
6 weeks booklet-delivered self-help cognitive behavioral therapy
Eligibility Criteria
You may qualify if:
- Hong Kong residents
- Aged 18 or above
- Able to read Chinese and write in Chinese or English
- Have a Patient Health Questionnaire-9 (PHQ-9) total score of 10 or higher indicating at least moderate level of depressive symptoms
- Willing to provide informed consent and comply with the trial protocol
- Have an Internet-enabled mobile device (iOS or Android operating system) (for data collection purposes)
You may not qualify if:
- Received psychotherapy for depression and/or insomnia in the past 6 months
- A change in psychotropic drugs or over-the-counter medications that target depression and/or insomnia within 2 weeks before the baseline assessment
- A PHQ-9 item-9 score equal to or higher than 2, indicating a moderate level of suicidal risk that requires active crisis management (referral information to professional mental health services will be provided)
- Currently participating in another interventional study that may potentially improve mental health
- Pregnancy
- Self-disclosure of having unsafe conditions for which physical activity or a change in diet was contraindicated by physicians or other health professionals (e.g., dietitian)
- Self-disclosure of a diagnosis of any major psychiatric, medical, or neurocognitive disorders that make participation unsuitable or interfere with the adherence to the interventions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Shatin, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Fiona Yan-Yee Ho, PhD
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 11, 2023
First Posted
January 20, 2023
Study Start
January 15, 2023
Primary Completion
August 31, 2023
Study Completion
December 31, 2023
Last Updated
January 20, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share